999久久久国产精品,亚洲精品无码一区二区卧室 ,亚洲精品久久久蜜桃,免费观看的国产大片app下载

荷蘭,Harbour Antibodies,
成立于2006年，作為公司的商業(yè)化轉基因小鼠在荷蘭鹿特丹 Erasmus醫(yī)學中心，荷蘭最大的醫(yī)療中心正在開發(fā)的人類抗體的平臺。

Harbour Antibodies BV was founded in 2006 as a company to commercialise transgenic mouse human antibody platforms being developed at the Erasmus MC in Rotterdam, the largest medical center in the Netherlands. Harbour licenses broadly across the pharma/biotech industry, and provides academic collaborators access to the transgenic mouse antibody platforms under MTA. In addition to the derivation of human H2L2 antibodies, transgenic mouse platforms have been developed for the derivation of novel human heavy chain only antibodies (HCAbs), soluble human VH domains and VH domain antibody complexes for use both as research tools and to meet unmet clinical need. The proprietary transgenic mouse platforms are protected by filed and granted patent applications in the major and the expanding healthcare markets.